Research Groups and R&D Platforms: Target discovery

Picture of Cecilia Sahlgren

Research Group:
Cell fate – from molecular understanding to control

Cecilia Sahlgren
cecilia.sahlgren[at]abo.fi, cecilia.sahlgren[at]bioscience.fi

Turku Bioscience Centre and
Faculty of Science and Engineering,
Åbo Aakdemi University

Cecilia Sahlgren

Cell fate

The Cell Fate Lab

Atomic-force microscopy, Basic research, Biochemistry, Biomarker, Biotechnology, Breast cancer, Cancer, Cardiovascular diseases, Data mining, Developmental disorders, Diagnostics, Disease models, Drug delivery, Drug target, Imaging, Imaging software, In Vivo Diagnostics, Molecular Cell Biology, Molecular modelling, Personalized medicine, PET, Proteomics, Receptor, Signaling, Super-resolution imaging, Target discovery

Research Group:
Molecular imaging of atherosclerosis and heart failure

Antti Saraste
antti.saraste[at]utu.fi

Heart Center and PET Center,
University of Turku

Antti Saraste

Basic research, Biomarker, Cardiovascular diseases, Clinical Medicine, Diabetes, Disease models, Imaging, In Vivo Diagnostics, Inflammation, PET, Target discovery, Ultrasound imaging

Research Group:
Synthetic Glycocluster Adjuvants

Johannes Savolainen
johsav[at]utu.fi

Department of Clinical Medicine,
University of Turku

Johannes Savolainen

Allergy, Asthma, Biomedicine, Biomolecular chemistry, Biotechnology, Cancer, Immunology, Inflammation, Melanoma, Natural Compounds, NMR, Organic Chemistry, Synthetic Biology, Synthetic chemistry, Target discovery

Research Group:
Alpha2-Adrenoceptors as targets for drug development

Mika Scheinin
mschein[at]utu.fi

University of Turku, Turku University Hospital and CRST Oy

Mika Scheinin

Clinical Research Services Turku

Ageing-related diseases, Allergy, Antibodies, Assay development, Asthma, Autoimmune diseases, Basic research, Biomarker, Biomedicine, Biopharmaceuticals, Cancer, Cardiovascular diseases, Clinical Medicine, Diabetes, Diagnostics, Disease models, Drug delivery, Drug target, Endocrinology, Imaging, In Vitro Diagnostics, In Vivo Diagnostics, Inflammation, Medicinal chemistry, Metabolic diseases, Metal disorders, Molecular diagnostics, Musculoskeletal disorders, Natural products, Neurological disorders, Obesity, Organic compounds, Personalized medicine, PET, Pharmacology, Receptor, Screening, Signaling, Skin diseases, Target discovery

Research Group:
Radiochemistry for development of radiotracers for Positron Emission Tomography

Olof Solin
olof.solin[at]abo.fi, olof.solin[at]utu.fi

Turku PET Centre and Department of Chemistry,
University of Turku

Olof Solin

Turku PET Centre

Ageing-related diseases, Autoimmune diseases, Biomarker, Cancer, Data mining, Diabetes, Disease models, Drug delivery, Drug stability, Drug target, Formulation, Imaging, Imaging software, In Vivo Diagnostics, Inflammation, Metabolic diseases, Molecular diagnostics, Molecular modelling, Nanoparticles, Neurological disorders, NMR, Nucleic acids, Obesity, Organic compounds, Particle size analysis, PET, Physico-chemical properties, Receptor, Signaling, Synthetic chemistry, Target discovery, Zeta potential

Research Group:
Molecular determinants of picornaviral disease

Petri Susi
pesusi[at]utu.fi

Institute of Biomedicine,
University of Turku

Petri Susi

AIROPico

Asthma, Basic research, Bioinformatics, Biomarker, Biotechnology, Cancer, Electron microscopy, Epidemiology, Genomics, Imaging, Imaging software, In Vitro Diagnostics, Infection, Molecular Biology, Molecular Cell Biology, Molecular modelling, Next-generation sequencing, Point of care, Target discovery, Virology